Skip to the page

Data / Form D filings / Premier Clinical Research, Inc.

Premier Clinical Research, Inc.: Form D filing

Premier Clinical Research, Inc., a health care company in Springboro, OH, filed a Form D with the SEC in 2023. The latest, on November 15, 2023, reports $10,000 sold of a $5.2 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
66 REMICK BOULEVARD, Springboro, OH, 45066
Phone
(937) 930-4050
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Ohio
Year incorporated
2023
Revenue range
$1,000,001 - $5,000,000
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2001008

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 15, 2023New notice$5,200,000$10,000$5,190,0001Nov 1, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Joshua OrdwayExecutive Officer, Director
Derek TiptonExecutive Officer, Director
Nicholas TiptonExecutive Officer, Director
Lynette TiptonExecutive Officer, Director

Other health care companies in Ohio that filed recently

Every Form D from the week of Nov 13, 2023 · All recent filings in Ohio · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Premier Clinical Research, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.